Episode

Navigating Challenges in Drug Discovery with Dr. Alfred Botchway

Podcast
BioTalk Unzipped
Published
Apr 7, 2025
Duration seconds
3112
Processing state
not_requested
Canonical source
https://biotalk-unzipped.captivate.fm/episode/alfbotchway
Audio
https://podcasts.captivate.fm/media/5e66f3b2-41b7-4c32-a438-5fb768e47d27/EP32-Alf-Botchway-1-MP3.mp3
JSON
/v1/public/podcasts/biotalk-unzipped-6702602/episodes/navigating-challenges-in-drug-discovery-with-dr-alfred-botchway
Markdown
/podcast/biotalk-unzipped-6702602/navigating-challenges-in-drug-discovery-with-dr-alfred-botchway.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/biotalk-unzipped-6702602/episodes/navigating-challenges-in-drug-discovery-with-dr-alfred-botchway/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/biotalk-unzipped-6702602/navigating-challenges-in-drug-discovery-with-dr-alfred-botchway.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alfred Botchway, CEO of Attentive Science, to discuss his journey in biomedical science and the groundbreaking work being done at the intersection of AI, non-clinical safety, and drug discovery. Dr. Botchway shares his insights on the role of AI in refining toxicology studies, how stress impacts human health, and his experience founding companies like Xenometrics and Attentive Science. The conversation dives deep into the complexities of Good Laboratory Practices (GLP), the importance of regulatory standards, and the exciting research happening in anxiety and PTSD treatments. Dr. Botchway also discusses the future of biomedical research, the need for greater collaboration between academia and industry, and how innovations in sample collection are transforming clinical trials. Whether you’re interested in AI, biomedical innovation, or the future of drug discovery, this episode offers valuable insights from a leader shaping the industry. Don’t forget to subscribe and let us know your thoughts in the comments below! Dr. Alfred Botchway https://www.linkedin.com/in/alfred-botchway-41b01a6/ CEO of Attentive Science: https://www.attentivescience.com/ Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/ Celerion - https://www.celerion.com/ Gregory Austin https://www.linkedin.com/in/gregoryaustin1/ Celerion - https://www.celerion.com/ 00:00 Introduction to BioTalk Unzipped 02:32 Dr. Alfred Botchway's Journey in Biomedical Science 03:48 Challenges Founding and Growing Xenometrics 07:30 Starting Attentive Science: A New Venture 09:37 Love of the Work - Variations 10:26 The Role of AI in Non-Clinical Safety Assessments 13:04 The Three Rs: Replace, Reduce, Refine, and AI 15:46 Regulatory…